InvestorsHub Logo
Followers 516
Posts 38725
Boards Moderated 5
Alias Born 04/26/2012

Re: None

Saturday, 12/26/2015 10:45:31 AM

Saturday, December 26, 2015 10:45:31 AM

Post# of 3023
ARYC continued it's great earnings with Q3 bringing in almost $620,000. Earnings for 2015 were $2.3 million. ARYC is currently trading at .0008 with 707 mill outstanding shares. Currently trading at .25 X Earnings. Get in before it returns to where it should be trading: .25+

Please DD ARYC, my friends.

ARYC: Arrayit is a leading edge developer, manufacturer and marketer of next-generation life science tools and integrated systems for the large scale analysis of genetic variation, biological function and diagnostics. Using Arrayit’s proprietary and patented technologies, the Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping, gene expression and protein analysis markets, and the Company expects to enter the market for manufacturing molecular diagnostics.

Arrayit has earned respect as a leader in the health care and life sciences industries with its proven expertise in three key areas: the development and support of microarray tools and components, custom printing and analysis of microarrays for research, and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states. As a result, Arrayit has provided tools and services to thousands of the leading genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies worldwide.

Check out their Facebook page and daily updates on Twitter.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.